|
|
|

|
 |
Park, Sang Ki, Ph.D.
|
|
Assistant Professor Department of Life
Science Division of Molecular and Life Sciences Neurobiology
|
|

|
|
|
|

|
|
Profile
| Research Interests
| Selected Publications
|
|

|
|
Profile
| 2001
|
Ph.D. University of Virginia
|
|
2001-2006
|
Postdoctoral Research Fellow, Harvard Medical School/Howard Hughes
Medical Institute
|
|
2006-2006
|
Postdoctoral Associate, Massachusetts Institute of Technology/Picower
Institute of Learning and Memory ·
|
|
2004-2008
|
NARSAD Young Investigator
|
|
2006. 9
|
Dept. of Life Science, Postech
|
|
|
TOP
|
|
|
Research Interests
Mental illness such as mood disorders, schizophrenia and drug addiction is one of the most prevalent diseases in modern human society. However, the molecular mechanisms underlying pathogenesis of those diseases are largely unknown. Recently, the Molecular Psychiatry - molecular neurobiological study of psychiatric disorders - has emerged as a promising research domain of the modern neuroscience, rendering a unique approach to further understanding the pathogenesis of various psychiatric disorders. To this end, the Laboratory of Molecular NeuroPsychiatry (L.MNP) pursues in depth understanding of the molecular basis of psychiatric disorders, utilizing contemporary biochemical, molecular biological, cell biological, pharmacological, genetic and behavioral biological techniques. We believe that the research will not only expand our knowledge on higher brain functions such as cognition, emotion, mood, reward, and motivation but also allow identification of novel molecular targets for therapies against major psychiatric disorders. Current specific research directions in the lab are as following.
1. Modulation of dopamine receptor-mediated signaling
Dopamine is one of the most functionally prevalent neurotransmitters in the vertebrate brain. Its role in higher brain functions is mediated by five subtypes of dopamine receptors. Among them dopamine D2 receptor (D2DR) has been implicated in various psychiatric diseases including attention deficit hyperactivity disorder (ADHD), mood disorders, schizophrenia and drug addiction. Thus detailed understanding of D2DR-mediated signaling mechanisms is thought to provide platform for elucidation of those related psychiatric problems. The L.MNP is attempting to identify modulatory components in D2DR-mediated signaling in the context of higher brain functions and the pathogenesis of associated disorders.
2. Dopamine signaling and depression
Par-4 is a modulator of D2DR-mediated signaling. As a disruption of the normal function of Par-4 is associated with depression-like behaviors in a mouse model, it is thought to play a significant role in the pathways linking dopamine signaling and normal mood control. The L.MNP pursues further understanding of the neural function of Par-4 in relation to mood disorders, evaluating potentials as a molecular target for novel anti-depression therapies.
3. Molecular modeling of schizophrenia
Schizophrenia is a psychiatric disorder that is thought to have both neurochemical aspects (imbalances in dopamine, glutamate and GABA neurotransmission) and neurodevelopmental aspects (neuronal positioning, neuronal polarity and neurite outgrowth) in its pathogenesis. The complexity of the pathogenesis has hindered establishment of the genuine animal model reflecting schizophrenic condition. Recently, advances in human genetics provided candidates genes causative in the expression of schizophrenia. The L.MNP attempts to understand their physiological function to establish animal models useful to elucidate the molecular basis of schizophrenia.
|
|
Selected Publications
- Kim J, Park BH, Lee JH, Park SK, and Kim
JH (2011),
Cell type-specific alterations
in the nucleus accumbens by repeated exposures
to cocaine. Biol Psychiatry 69;1026-1034
- Chansard M, Wang J, Tran HC, Neumayer G,
Shim SY, Park YU, Belzil C, Le HC, Park SK and
Nguyen MD (2011),
The Cytoskeletal Protein
Ndel1 Regulates Dynamin 2 GTPase Activity. PLoS
One 6(1):e14583.
- Park YU, Jeong J, Lee H, Mun JY, Kim JH,
Lee JS, Nguyen MD, Han SS, Suh PG, and Park
SK (2010),
Disrupted-in-schizophrenia 1
(DISC1) plays essential roles in mitochondria
in collaboration with Mitofilin.Proc Natl Acad
Sci USA 107(41): 17785-90.
- Lee S, Jeong J, Kwak Y, and Park SK (2010),
Depression research: where are we now?.
Mol Brain 3:8-17.
- Kim J, Jung SY, Lee YK, Park SK, Choi JS,
Lee CJ, Kim HS, Choi YB, Scheiffele P, Bailey
CH, Kandel ER, and Kim JH (2008),
Neuroligin-1
is required for normal expression of LTP and
associative fear memory in the amygdala of adult
animals. Proc Natl Acad Sci USA 105(26): 9087-9092.
- Park SK, George R, Cai Y, Chang HY, Krantz
DE, Friggi-Grelin F, Birman S and Hirsh J (2006),
Cell type-specific limitation on in vivo
serotonin storage following ectopic expression
of the Drosophila serotonin transporter, dSERT.J
Neurobiol 66:452-62.
- Park SK, Nguyen MD, Fischer A, Affar EB,
Luke MP, Dieffenbach PB, Tseng HC, Shi Y. and
Tsai LH (2005),
Par-4 links dopamine signaling
and depression. Cell 122:275-287
|
|
|
|

|
|
Division
of Molecular & Life Sciences| POSTECH |
|